The 145th Annual Meeting of the Pharmaceutical Society of Japan (Fukuoka)
Advanced Search

Session Details

Symposium

[S27]A New Frontier in Cancer Therapy: Exploring the Potential of At-211

Fri. Mar 28, 2025 10:15 AM - 11:45 AM JST
Fri. Mar 28, 2025 1:15 AM - 2:45 AM UTC
Room 6 (Fukuoka International Congress Center: 203 [2F])
Organizer: Takeshi Fuchigami (Grad. Sch. Pharm., Kanazawa Univ.), Hiroyuki Suzuki (Grad. Sch. Pharm., Chiba Univ.)
10:15 AM - 10:20 AM JST(1:15 AM - 1:20 AM UTC)

本シンポジウムの趣旨：淵上 剛志（金沢大院薬）

10:20 AM - 10:36 AM JST(1:20 AM - 1:36 AM UTC)

[S27-1]Global Trends in Targeted Alpha Therapy and Current Status of Alpha-emitting Radionuclide Production in Japan

○Kohshin Washiyama1 (1. ACRC, Fukushima Med. Univ.)
10:36 AM - 10:52 AM JST(1:36 AM - 1:52 AM UTC)

[S27-2]Development and evaluation of At-211 labeled peptides

○Kazuma Ogawa1,2 (1. INFINITI, Kanazawa Univ., 2. Grad. Sch. Pharm., Kanazawa Univ.)
10:52 AM - 11:08 AM JST(1:52 AM - 2:08 AM UTC)

[S27-3]Attempts to improve the in vivo stability of At-211 labeled agents

○Hiroyuki Suzuki1 (1. Grad. Sch. Pharm., Chiba Univ.)
11:08 AM - 11:24 AM JST(2:08 AM - 2:24 AM UTC)

[S27-4]Molecular mechanisms of antitumor effect in targeted alpha-radionuclide therapy

○Yasuhiro Ohshima1 (1. QST Takasaki)
11:24 AM - 11:40 AM JST(2:24 AM - 2:40 AM UTC)

[S27-5]Clinical application of targeted alpha-ray therapy using astatine

○Tadashi Watabe1 (1. Grad. Sch. Med., Osaka Univ.)
11:40 AM - 11:45 AM JST(2:40 AM - 2:45 AM UTC)

総括・今後の展望と課題：淵上 剛志（金沢大院薬）

Back to Category List